SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-19-007095
Filing Date
2019-04-12
Accepted
2019-04-12 16:33:33
Documents
6
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A nby20190411_10ka.htm 10-K/A 135543
2 EXHIBIT 23.1 ex_140491.htm EX-23.1 2673
3 EXHIBIT 31.1 ex_140492.htm EX-31.1 8946
4 EXHIBIT 31.2 ex_140493.htm EX-31.2 9033
5 EXHIBIT 32.1 ex_140494.htm EX-32.1 4440
6 EXHIBIT 32.2 ex_140495.htm EX-32.2 4317
  Complete submission text file 0001437749-19-007095.txt   165962
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33678 | Film No.: 19746655
SIC: 2834 Pharmaceutical Preparations